LPCN Lipocine Inc.
Healthcare$2.26+1.80%ClosedMarket Cap: $13.1M
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$10.50
Target (Median)
$10.50
Target Range
$6.00 - $15.00
Upside from current price: 364.6%
Rating Distribution
0 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-06 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2026-01-21 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-20 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-06-27 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.65 | $1.1M | 1 |
| Sun Dec 31 | $-0.95 | $1.2M | 1 |
| Mon Dec 31 | $-0.75 | $2.9M | 1 |
| Tue Dec 31 | $-0.35 | $9.4M | 1 |